MedTrace Logo

Effects of Iron Therapy and Exercise Training in Patients With Heart Failure and Iron Deficiency

NCT03803111 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2022-03-16

No results posted yet for this study

Summary

It is the aim of the study to prove, if intravenous supplementation with ferric carboxymaltose in iron-deficient patients with heart failure with reduced ejection fraction (HFrEF) leads to better exercise training effects compared to exercise training without previous iron supplementation.

Conditions

  • Heart Failure With Reduced Ejection Fraction
  • Exercise Training
  • Ferric Carboxymaltose

Interventions

BEHAVIORAL

Initial exercise training

Initial exercise training program

DRUG

Initial FCM

Initial intravenous iron supplementation (FCM)

DRUG

Subsequent FCM

Subsequent intravenous iron Supplementation (FCM) after 2 months

BEHAVIORAL

Subsequent exercise training

Subsequent exercise training program after 2 months

Sponsors & Collaborators

  • Herzzentrum Bremen

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2022-03-15
Completion
2022-03-15

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03803111 on ClinicalTrials.gov